company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4643000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4643000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4643000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3116000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7283000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,134000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10533000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5890000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-65000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,803000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,738000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5152000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5152000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5152000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5152000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54836000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54836000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 14:27:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14448000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14448000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14448000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3635000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8227000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,120000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11982000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2466000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,118000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,749000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,867000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3333000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3333000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3333000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3333000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54844000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55648000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:25:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12512000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12512000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12512000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3156000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7317000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10573000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1939000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,119000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,824000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,943000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2882000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2882000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2882000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2882000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54983000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56114000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:36:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12157000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12157000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12157000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2809000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8176000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,76000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11061000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1096000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,120000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,760000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,880000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1976000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1976000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1976000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1976000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55209000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56434000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49400000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 16:38:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41634000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41634000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41634000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3825000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7456000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-87000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11194000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30440000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,102000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,840000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,942000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,31382000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31382000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31382000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31382000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55248000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56378000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q3,2011-07-01,2011-09-30,2012-10-31 16:30:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11110000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11110000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11110000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2668000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8002000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-7000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10663000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,447000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,807000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,884000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1331000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1331000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1331000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1331000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55176000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56347000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55300000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11267000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11267000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11267000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3671000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9388000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13059000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1792000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,121000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,785000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,906000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-886000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-886000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-886000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-886000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63409000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 16:57:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10569000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10569000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10569000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11949000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1380000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,115000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,764000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,879000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-501000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66309000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 14:13:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9357000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9357000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9357000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3324000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9860000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,135000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13319000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3962000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,123000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,761000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,884000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66342000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 16:48:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21947000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21947000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21947000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3311000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9097000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,957000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13365000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8582000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,130000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,778000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,908000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65619000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66946000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62800000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3392000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10313000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13705000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12975000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,103000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,797000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,900000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12075000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12075000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12075000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12075000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 13:49:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3370000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10527000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13897000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13167000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,121000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,804000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,925000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12242000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12242000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12242000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12242000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66799000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:54:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,729000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,729000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,729000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3245000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9490000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12735000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12006000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,93000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,782000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,875000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11131000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67199000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 12:58:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3342000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8918000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12260000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11530000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,85000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,803000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,888000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10642000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10642000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10642000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10642000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66989000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66989000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66800000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4153000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8572000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12725000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12725000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,89000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,794000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,883000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11842000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11842000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11842000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11842000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70260000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 14:59:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10161000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14361000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14361000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,167000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,813000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,980000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13381000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13381000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13381000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13381000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74300000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74300000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75879000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:45:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4663000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12194000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16857000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16857000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,176000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,806000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,982000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15875000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15875000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15875000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15875000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75948000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q3,2014-07-01,2014-09-30,2015-10-29 16:29:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4970000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15498000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20468000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20468000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,197000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,827000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1024000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19444000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19444000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19444000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19444000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74577000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74577000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19769000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19769000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19769000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5482000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16575000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22057000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2288000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,257000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,839000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1096000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1192000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1192000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1192000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1192000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,119200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80349000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:38:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6603000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18719000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25322000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25322000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,506000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,829000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1335000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23987000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23987000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23987000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23987000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85518000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:25:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11456000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24388000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35844000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35844000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,581000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,828000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1409000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34435000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34435000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34435000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34435000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85856000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:30:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8939000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21809000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30748000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30748000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,584000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,849000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1433000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29315000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29315000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29315000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29315000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84496000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84496000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11954000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23903000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35857000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20857000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,737000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,856000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1593000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19264000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86497000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:59:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14965000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26863000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41828000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41828000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,680000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,868000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1548000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40280000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40280000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40280000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40280000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86694000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:17:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17494000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20942000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38436000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38436000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,705000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,844000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1549000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36887000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85800000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85800000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86784000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:24:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23668000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22583000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46251000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46251000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4160000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2568000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1592000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44659000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44659000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44659000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44659000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86713000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86713000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28050000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51882000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79932000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-79932000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,727000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,879000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1606000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-78326000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78326000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78326000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-78326000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.9
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.9
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87283000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q1,2017-01-01,2017-03-31,2018-04-30 16:40:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.9
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6335000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6335000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6274000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41674000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21868000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63542000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57268000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4767000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2050000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2717000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88063000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:19:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60774000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60774000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,433000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,433000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60341000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43873000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22463000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66336000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5995000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7337000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2207000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5130000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11125000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11125000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11125000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11125000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88325000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88325000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:15:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94517000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94517000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,760000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,760000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93757000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56309000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25614000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81923000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11834000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7419000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7615000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5136000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4940000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6894000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6894000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6894000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6894000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88089000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88089000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71086000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71086000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,950000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,950000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70136000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58636000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48947000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107583000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37447000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7504000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3133000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4371000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41818000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89526000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89526000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:30:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89526000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,96905000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,96905000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,854000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,854000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,96051000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60915000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36988000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,97903000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1852000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7591000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3530000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4061000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5913000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5913000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5913000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5913000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:23:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,151757000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,151757000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1551000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1551000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,150206000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60401000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35482000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,95883000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54323000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7672000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4113000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3559000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,50764000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50764000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,50764000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,50764000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90555000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,96798000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:18:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,131492000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,131492000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1534000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1534000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,129958000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68980000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39107000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,108087000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21871000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7763000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15476000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10776000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3063000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18808000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,730000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18078000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90235000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95386000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91800000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,138400000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,138400000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,137300000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,87500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,150800000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,238300000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-101000000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7900000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6300000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-102600000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-102100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-102100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.12
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91100000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.12
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:20:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.12
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,183580000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,183580000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1608000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1608000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,181972000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80824000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,66687000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,147511000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34461000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7942000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25572000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,17630000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,52091000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,753000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51338000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51338000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51338000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91389000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,94779000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91700000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:23:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,222094000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,222094000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2229000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2229000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,219865000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,84489000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45278000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,129767000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,90098000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8038000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23653000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-31691000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,58407000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4618000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53789000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,53789000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,53789000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91859000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,96074000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91200000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:18:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,244013000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,244013000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2491000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2491000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,241522000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,101249000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,91549000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,192798000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,48724000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8083000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19209000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21206000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10080000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,38644000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4659000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33985000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91627000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95732000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92500000.0
Neurocrine Biosciences Inc,NBIX,,0000914475,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
